Back to User profile » Prof. Dr. Ding Ma
Papers published by Prof. Dr. Ding Ma:
TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy
Jiang G, Wang X, Zhou Y, Zou C, Wang L, Wang W, Zhang D, Xu H, Li J, Li F, Luo D, Ma X, Ma D, Tan S, Wei R, Xi L
International Journal of Nanomedicine 2021, 16:4087-4104
Published Date: 15 June 2021
Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Retraction]
Yu L, Wang XL, Zhu D, Ding W, Wang L, Zhang C, Jiang X, Shen H, Liao S, Ma D, Hu Z, Wang H
OncoTargets and Therapy 2017, 10:2835-2836
Published Date: 2 June 2017
Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy
Chen Z, Huang K, Lu Z, Deng S, Xiong J, Huang J, Li X, Tang F, Wang Z, Sun H, Wang L, Zhou S, Wang X, Jia Y, Hu T, Gui J, Wan D, Ma D, Li S, Wang S
OncoTargets and Therapy 2016, 9:3171-3179
Published Date: 27 May 2016
Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Corrigendum]
Yu L, Wang XL, Zhu D, Ding WC, Wang LM, Zhang CL, Jiang XH, Shen H, Liao SJ, Ma D, Hu Z, Wang H
OncoTargets and Therapy 2015, 8:365-366
Published Date: 4 February 2015
Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells
Yu L, Wang XL, Zhu D, Ding WC, Wang LM, Zhang CL, Jiang XH, Shen H, Liao SJ, Ma D, Hu Z, Wang H
OncoTargets and Therapy 2015, 8:37-44
Published Date: 22 December 2014